QSAR of genotoxic active benzazoles

SAR and QSAR in Environmental Research

Volumn 18, Issue 3-4, 2007, Pages 251-263

  Tekiner Gulbas, B ^a   Temiz Arpaci, O ^a   Oksuzoglu, E ^b   Eroglu, H ^b   Yildiz, I ^a   Diril, N ^b   Aki Sener, E ^a   Yalcin, I ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Benzimidazoles; Benzoxazoles; Genotoxic activity; QSAR

Indexed keywords

COMPUTATIONAL CHEMISTRY; QUANTUM CHEMISTRY;

BACILLUS SUBTILIS; BENZAZOLES; BENZIMIDAZOLE DERIVATIVES; BENZIMIDAZOLES; BENZOXAZOLE; BENZOXAZOLE DERIVATIVES; GENOTOXIC; GENOTOXIC ACTIVITY; QSAR; SYNTHESISED;

BACTERIOLOGY;

BACILLUS SUBTILIS;

EID: 34249036722     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629360701303966     Document Type: Article

References (46)

1. I. Oren-Yildiz, I. Yalcin, E. Aki-Sener, N. Ucarturk. Eur. J. Med. Chem., 39, 291 (2004).
2. I. Oren-Yildiz, B.P. Tekiner-Gulbas, I. Yalcin, O. Temiz-Arpaci, E. Aki-Sener, N. Altanlar. Arch Pharm. Pharm. Med. Chem., 337, 402 (2004).
3. R.K. Plemper, K.J. Erlandson, A.S. Lakdawala, A. Sun, A. Prussia, J. Boonsombat, E. Aki-Sener, 1. Yalcin, I. Yildiz, O. Temiz-Arpaci, B.P. Tekiner, D. Liotta, J.P. Snyder. Proc. Natl. Acad. Sci. USA, 101, 5628 (2004).
4. H. Lage, E. Aki-Sener, I. Yalcin. Int. J. Cancer, 119, 213 (2006).
5. A. Pinar, P. Yurdakul, I. Yildiz, O. Temiz-Arpaci, N.L. Acan, E. Aki-Sener, I. Yalcin. Biochem. Biophys. Res. Commun., 317, 670 (2004).
6. B. Tekiner-Gulbas, O. Temiz-Arpaci, I. Yildiz, E. Aki-Sener, I. Yalcin. SAR QSAR Environ. Res., 17, 121 (2006).
7. Cancer quest: Cancer treatments: Chemotheraphy genotoxic drugs. Available online at: www.Cancerquest.org/index.cfm?page0482 (Accessed 19 May 2006).
8. J. Blasiak, J. Kowalik. Acta Biochimica Polonica, 48, 233 (2001).
9. L.R. Ferguson, A.E. Pearson. Mutat. Res., 17, 1 (1996).
10. A. Eastman, M.A. Barry. Cancer Invest., 10, 229 (1992).
11. M.F. Rajewsky, J. Engelbergs, J. Thomale, T. Schweer. Mutat. Res., 462, 101 (2000).
12. N. Schiavone, L. Papucci, P. Luciani, A. Lapucci, M. Donnini, S. Capacioli. Biochem. Biophys. Res. Commun., 270, 406 (2000).
13. J. Aubrecht, R. Krishna-Narla, P. Ghosh, J. Stanek, F.M. Uckun. Toxicol. Appl. Pharm., 154, 228 (1999).
14. D. Gotto, H. Izumi, M. Ono, T. Okamoto, K. Kohno, M. Kuwano. Angiogenesis, 2, 345 (1999).
15. K.J. Yarema, S.J. Lipard, J.M. Essigmann. Nucleic Acids Res., 23, 4066 (1995).
16. G. Li, H. Alexander, N. Schneider, S. Alexander. Microbiology, 146, 2219 (2000).
17. W.N. Keith, R. Brown. Anticancer Res., 11, 1739 (1991).
18. M. Lujungman, D.P. Lane. Nat. Rev. Cancer, 4, 727 (2004).
19. I. Yalcin, E. Sener. Int. J. Pharm., 98, 1 (1993).
20. I. Oren, O. Temiz, I. Yalcin, E. Sener, A. Akin, N. Ucarturk. Arzneim. Forsch., 47, 1393 (1997).
21. A. Akbay, I. Oren, O. Temiz-Arpaci, E. Aki-Sener, I. Yalcin. Arzneim. Forsch., 53, 266 (2003).
22. E. Oksuzoglu, The investigation of genotoxic potentials of benzoxazole derivatives and their cyclic analogs, and inhibitory effects of these compounds on cukaryotic DNA topoisomerase I and II. MSc. Thesis, Faculty of Science, Department of Molecular Biology, Hacettepe University, (2004).
23. T. Yamaguchi. Mutat. Res., 224, 493 (1989).
24. M.K. Sharma, R.C. Sobti. Mutat. Res., 465, 27 (2000).
25. T. Kada, K. Hirano, Y. Shirasu. In Chemical Mutagens. Principles and Methods for their Detection, F.J. Serres and A. Hollaender (Eds), pp. 149-173, Plenum Publishing Corporation, New York (1980).
26. Y. Sakagami, K. Yasamaki, H. Yokoyama, Y. Ose, T. Sato. Mutat. Res., 193, 21 (1988).
27. H. Takigami, S. Matsui, T. Matsuda, Y. Shimizu. Waste Manage., 22, 209 (2002).
28. H. Kubinyi. In QSAR: Hansch Analysis and Related Approaches, R. Mannhold, P. Krogsgaard-Larsen, and H. Timmerman (Eds), p. 54, Wiley-VCH, Weinheim (1993).
29. H. Kubinyi. J. Med. Chem., 19, 587 (1976).
30. H. Kubinyi. In QSAR: Hansch Analysis and Related Approaches, R. Mannhold, P. Krogsgaard-Larsen, and H. Timmerman (Eds), p. 63, Wiley-VCH, Weinheim (1993).
31. R. Franke. In Theoretical Drug Design Methods, W.Th. Nauta and R.F. Rekker (Eds), p. 257, Elsevier, Amsterdam (1984).
32. H. Kubinyi. In Comprehensive Medicinal Chemistry Vol. 4, C.A. Ramsden (Ed.), P. 594, Pergamon Press, Oxford (1990).
33. C. Hansch, A. Leo, D. Hoekman. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants, American Chemical Society, Washington, DC (1995).
34. Accelrys Inc. Cerius2 (2004).
35. http://www.kubinyi.de/bilin-program.html
36. MINITAB Release 13.1, http://www.minitab.com
37. N. Draper, H. Smith. Applied Regression Analysis, John Wiley & Sons, New York (1966).
38. J.O. Rawlings. Applied Regression Analysis, pp. 186-189, Wadsworth & Brooks/Cole, Pacific Grove, CA (1988).
39. S. Wold. Quant. Struct.-Act. Relat., 10, 191 (1991).
40. T. Yamaguchi. Mutat. Res., 224, 493 (1989).
41. T. Kada, K. Hirano, Y. Shirasu. In Chemical Mutagens Vol 6, F. Serres and A. Hollaender (Eds), p. 149, Plenum Publishing Corporation, New York (1980).
42. Y.Q. Shi, T. Fukai, H. Sakagami, J. Kuroda, R. Miyaoka, M. Tamura, N. Yoshida, T. Nomura. Anticancer Res., 21, 2847 (2001).
43. M. Konishi, T. Oki. In Enediyne antibiotics as antitumor agents, D.B. Borders and T. Doyle (Eds), pp. 301-325, Marcel Dekker, New York (1995).
44. H. Kubinyi. In QSAR: Hansch Analysis and Related Approaches, R. Mannhold, P. Krogsgaard-Larsen, and H. Timmerman (Eds), pp. 91-95, Wiley-VCH, Weinheim (1993).
45. H. Kubinyi. In QSAR: Hansch Analysis and Related Approaches, R. Mannhold, P. Krogsgaard-Larsen, and H. Timmerman (Eds), p. 59, Wiley-VCH, Weinheim (1993).
46. L.L. Chen, J.B. Yad, J.B. Yang, J. Yang. Acta Pharm. Sinica, 26, 1322 (2005).